Genentech's native HIC-MS method uses ammonium tartrate, enabling efficient MS detection without compromising chromatographic ...
Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: Tokyo Friday, February 6, 2026, 10:00 Hrs [I ...
Public health officials in Chicago have issued an urgent alert for a severe, fast-moving bacterial infection that can attack ...
Perfect Corp. , the leading AI and AR beauty and fashion technology provider and developer of ?Beautiful AI' solutions, today announced the launch of two powerful new content creation tools within the ...
The 2 nd Next-Generation Conjugates Summit, designed to help you push the boundaries of bioconjugate drug development with next-generation payloads and formats to improve translation and show a ...
The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to 30+ ...
Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR-Mutant Non–Small-Cell Lung Cancer
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer Interestingly, ...
The first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. DS3790 is a specifically engineered, ...
Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein–polysaccharide conjugate vaccines in developed countries over the past ...
Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Choose a character, then add, subtract, divide and multiply numbers to battle your way to victory in this fun maths game. Challenge yourself across 11 KS2 maths topics from the Mysterious Mountains of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results